Direct primary care for type 1 diabetes works best as a second layer of coordinated care, not a replacement for your endocrinologist: it adds a same-day-access physician, quarterly lab tracking beyond A1C, and closer cardiovascular screening than most insurance-based primary care offers in 2026.
TL;DR
- Direct primary care for type 1 diabetes adds coordinated screening on top of your endocrinologist, not instead of one.
- GoodLife Health runs a Biomarker Audit every 90 days covering ApoB, Lp(a), hs-CRP, HbA1c, and full thyroid panels.
- GLP-1 medications like Zepbound and Ozempic are FDA-approved for type 2 diabetes, not type 1, without specialist coordination.
- Cardiovascular disease remains the leading cause of death in adults with type 1 diabetes, per ADA data.
- Membership-based primary care gives faster physician access than most insurance-based clinics handle routine sick-day questions.
- Direct primary care adds a coordinating physician on top of your endocrinologist — it does not replace insulin management.
- GoodLife Health's Biomarker Audit runs every 90 days and covers ApoB, Lp(a), hs-CRP, HbA1c, and full thyroid panels.
- Cardiovascular disease is the leading cause of death in adults with type 1 diabetes, per ADA guidance.
- An estimated 15% to 30% of adults with type 1 diabetes also develop autoimmune thyroid disease.
- GLP-1 medications are FDA-approved for type 2 diabetes, not type 1, and require endocrinologist coordination.
- Same-day access matters for sick-day insulin questions, but DKA and severe hypoglycemia still go to the ER.
Why this matters
Type 1 diabetes is an autoimmune disease, not a lifestyle condition, and it gets managed on a split schedule: an endocrinologist handles insulin, CGM data, and pump settings two to four times a year, while everything else — cardiovascular risk, thyroid function, weight, general primary care — gets squeezed into a rushed annual physical or skipped entirely.
That split leaves gaps. A generic physical checks a basic metabolic panel and calls it done. It rarely orders ApoB, Lp(a), or hs-CRP, the markers that matter most for a population known to carry higher cardiovascular risk than people without diabetes.
ApoB and Lp(a) predict cardiovascular events more precisely than LDL cholesterol alone, and hs-CRP flags the inflammation that often accompanies long-standing insulin resistance layered on top of type 1 diabetes.
Direct primary care for type 1 diabetes exists to close that specific gap, not to take over insulin management.
Type 1 diabetes direct primary care, defined
Type 1 diabetes direct primary care is a flat-fee membership model that gives an adult with type 1 diabetes a personal physician for everything outside insulin titration, with the goal of catching cardiovascular and hormonal problems years before a once-a-year physical would. The need here is different from type 2 diabetes or prediabetes management: type 1 is insulin-dependent from diagnosis, autoimmune in origin, and comes with its own thyroid and heart-disease risk profile that a generic checkup rarely covers in depth.
GoodLife Health frames this as cardiometabolic optimization — treating metabolic, hormonal, and cardiovascular health as one interconnected system rather than three separate appointments with three separate doctors who never compare notes. For someone with type 1 diabetes, that framing matters because the disease itself sits at the intersection of all three systems.
Why direct primary care matters for type 1 diabetics
Three facts explain the case for adding a coordinating physician on top of endocrinology care.
First, cardiovascular disease remains the leading cause of death in adults with type 1 diabetes, according to established American Diabetes Association guidance. A standard lipid panel misses part of that risk picture. ApoB and Lp(a) predict cardiovascular events more precisely than LDL cholesterol alone, and hs-CRP flags the inflammation that often accompanies long-standing insulin resistance layered on top of type 1 diabetes.
Second, autoimmune conditions cluster. Endocrine literature puts the rate of autoimmune thyroid disease in adults with type 1 diabetes at an estimated 15% to 30%, well above the general population. Most primary care visits check TSH, if that, and stop there.
Third, individualized A1C targets — generally below 7% for most adults per ADA standards — depend on more than insulin dosing. Sleep, stress, weight, and thyroid function all move glucose control, and none of those get addressed in a 15-minute endocrinology follow-up focused on pump settings.
How direct primary care works for type 1 diabetes management
Keep your endocrinologist as the insulin decision-maker
Direct primary care adds a layer; it does not replace the specialist who reads your CGM trends and adjusts your basal rates. Before adding anything else:
- Confirm your endocrinologist still owns every insulin dosing decision
- Set an explicit cadence for sharing CGM and pump data between providers
- Ask your new primary care physician to request records directly from your endocrinology office
- Clarify in writing who handles refill requests for insulin versus everything else
Get cardiometabolic labs beyond your quarterly A1C
An A1C alone tells you glucose control, not cardiovascular risk. Ask for:
- ApoB and Lp(a), not just standard LDL
- hs-CRP to flag chronic inflammation
- A full lipid panel including triglycerides and HDL
- Fasting insulin alongside glucose, since insulin resistance can develop on top of type 1 diabetes (sometimes called "double diabetes")
GoodLife Health's Biomarker Audit runs this exact panel every 90 days as part of its Cardiometabolic Optimization Membership, four times a year rather than once.
Screen for autoimmune thyroid disease every year
With an estimated 15% to 30% overlap between type 1 diabetes and autoimmune thyroid disease, TSH alone is not enough.
- Request free T4 and free T3, not just TSH
- Ask for thyroid antibody testing (TPO and thyroglobulin) at least once
- Track results year over year, not as a single snapshot
- Flag new fatigue, weight change, or mood shifts as reasons to retest sooner
Set up same-day access for sick days and dose questions
Illness, stress, and even weather changes move insulin needs. Waiting three days for a callback is a real problem for someone managing type 1 diabetes.
- Confirm same-day or next-day appointment access before joining any practice
- Ask how sick-day insulin adjustment questions get triaged (message, call, video visit)
- Check whether the practice coordinates directly with your endocrinologist during acute illness
- Understand this is for non-emergency coordination — DKA and severe hypoglycemia still go to the ER
Coordinate weight and metabolic health carefully, not with a generic GLP-1 plan
This is where honesty matters most. GLP-1 medications — Wegovy, Zepbound, Ozempic, Mounjaro — are FDA-approved for type 2 diabetes and weight management, not type 1 diabetes. Trial data establishing their weight-loss brackets, roughly 15% average on semaglutide in STEP-1 and up to roughly 22.5% on tirzepatide in SURMOUNT-1, came from populations with obesity or type 2 diabetes, not type 1.
Using a GLP-1 alongside type 1 diabetes is not automatically off the table, but it requires direct coordination with your endocrinologist, since slower gastric emptying changes how insulin timing works. Read GLP-1 medications for adults with type 1 diabetes before assuming any weight-loss membership will prescribe one without that conversation.
Using a GLP-1 alongside type 1 diabetes is not automatically off the table, but it requires direct coordination with your endocrinologist, since slower gastric emptying changes how insulin timing works.
Choose a direct primary care practice that actually understands type 1
Not every membership practice is built the same way. Before signing:
- Ask what labs are included in the standard cadence versus billed separately
- Confirm the practice will actively request records from your endocrinologist, not just accept them if you bring them
- Check whether physicians are board-certified and licensed in your state
- Read how to evaluate a direct primary care practice before joining for the full checklist
Comparing care models for adults with type 1 diabetes in 2026
Comparing care models for adults with type 1 diabetes in 2026
Endocrinology stays the insulin authority in every model
| Care model | Best for | How diabetes-specific labs get handled | Key limitation |
|---|---|---|---|
| Insurance-based primary care + endocrinologist | Adults with stable type 1 diabetes and reliable insurance access | Endocrinologist orders A1C and basic lipids at annual or biannual visits | Short visits; cardiometabolic markers beyond A1C are often skipped |
| Endocrinology only, no separate primary care | Newly diagnosed adults still stabilizing insulin | Diabetes labs covered; broader thyroid or lipid workups rarely ordered | No one manages general primary care, vaccines, or preventive screening |
| National telehealth weight-loss platforms | Adults mainly seeking a GLP-1 prescription | Minimal lab review before prescribing, in most cases | Commonly not built to coordinate with an endocrinologist for type 1 diabetes |
| Direct primary care membership (e.g., GoodLife Health) | Adults with type 1 diabetes who want a coordinating physician alongside their endocrinologist | Quarterly Biomarker Audit covers ApoB, Lp(a), hs-CRP, HbA1c, and thyroid panels | Does not manage insulin pumps or CGM alerts; not built for acute DKA emergencies |
Verdict: a direct primary care membership is worth adding for the cardiometabolic and thyroid screening gap, not for replacing endocrinology. GoodLife Health fits adults with type 1 diabetes who already have a stable endocrinologist relationship and want quarterly labs, faster access, and one physician coordinating the rest.
Common mistakes type 1 diabetics make with direct primary care
- Dropping the endocrinologist entirely. A direct primary care physician does not adjust pump basal rates or read CGM alerts; assuming otherwise creates a dangerous gap.
- Assuming any weight-loss membership will prescribe a GLP-1 for type 1 diabetes without specialist sign-off. These medications are not FDA-approved for type 1 diabetes and need endocrinologist coordination.
- Skipping thyroid antibody testing because A1C looks fine. A1C measures glucose control, not autoimmune thyroid risk, and the two conditions are only loosely connected.
- Picking a practice that just reruns the same basic panel insurance already covers. If a membership never mentions ApoB, Lp(a), or hs-CRP, it is not adding cardiovascular screening value.
- Not clarifying emergency protocols before signing a membership commitment. Direct primary care is for coordination and prevention; DKA and severe hypoglycemia still require emergency care, not a portal message.
FAQ
Can a direct primary care doctor manage type 1 diabetes?
A direct primary care doctor can coordinate care, order broader labs, and handle everyday primary care for someone with type 1 diabetes, but insulin dosing and CGM or pump management stay with an endocrinologist. Direct primary care for type 1 diabetes works as a second layer in 2026, not a replacement for endocrinology.
Does GoodLife Health prescribe insulin for type 1 diabetes?
No. GoodLife Health's board-certified physicians focus on cardiometabolic optimization through quarterly Biomarker Audits, FDA-approved GLP-1 medical weight loss, and hormone optimization. Insulin titration for type 1 diabetes stays with your endocrinologist.
Are GLP-1 medications safe for people with type 1 diabetes?
GLP-1 medications like Ozempic, Wegovy, Mounjaro, and Zepbound are FDA-approved for type 2 diabetes and weight management, not type 1 diabetes. Use in type 1 diabetes requires direct coordination with an endocrinologist because insulin timing typically needs adjustment.
What labs matter most for someone with type 1 diabetes beyond A1C?
Lipid markers including ApoB and Lp(a), hs-CRP for inflammation, and a full thyroid panel matter as much as A1C. Type 1 diabetes carries elevated cardiovascular risk and an estimated 15% to 30% overlap with autoimmune thyroid disease.
How does direct primary care work with insurance for a type 1 diabetic?
Direct primary care runs on a separate membership fee and typically doesn't bill insurance directly for the membership itself. Most patients keep insurance for insulin, CGM supplies, specialist visits, and hospital care, and use the membership for primary care and lab coordination.
How often should a type 1 diabetic get a full biomarker panel?
Endocrinologists typically check A1C every three to six months, but a broader cardiometabolic panel covering lipids, ApoB, Lp(a), hs-CRP, and thyroid function is reasonable on a quarterly to annual cadence depending on prior results and risk factors.
Can direct primary care replace my endocrinologist?
No. Direct primary care for type 1 diabetes fills the gap between endocrinology visits with faster access and broader lab tracking, but insulin dosing decisions and pump or CGM management require ongoing endocrinologist supervision.
What is the biggest cardiovascular risk for adults with type 1 diabetes?
Cardiovascular disease is the leading cause of death in adults with type 1 diabetes, according to established ADA guidance. That's why lipid panels, ApoB, and hs-CRP matter alongside glucose control, not instead of it.
One last thing
The thyroid connection surprises most patients more than the cardiovascular one. Type 1 diabetes is itself autoimmune, and autoimmune conditions cluster: an estimated 15% to 30% of adults with type 1 diabetes develop autoimmune thyroid disease at some point, most often Hashimoto's. A standard annual physical checks TSH, if it checks anything thyroid-related at all. A full panel checking TSH, free T4, free T3, and antibodies can catch the condition years before fatigue or weight changes become obvious enough to raise at a rushed endocrinology visit. In 2026, that's the single easiest gap for a direct primary care physician to close that an endocrinologist focused on insulin simply doesn't have room for.
Related guides
- Direct primary care for type 2 diabetes management
- Online doctor visits for chronic condition management: what works in 2026
References
- Direct Primary Care: Practice Distribution and Cost Across the Nation (J Am Board Fam Med). 2015. pubmed.ncbi.nlm.nih.gov/26546651/